PubMed:10820269 / 1132-1427
Annnotations
c_corpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T514 | 82-86 | D020782 | denotes | MMPs |
| T515 | 128-139 | GO:0009056 | denotes | degradation |
| T517 | 151-171 | GO:0031012 | denotes | extracellular matrix |
| T518 | 165-171 | UBERON:0027368 | denotes | matrix |
| T519 | 172-181 | CHEBI:25367 | denotes | molecules |
| T520 | 207-220 | UBERON:0004537 | denotes | blood vessels |
| T521 | 250-260 | D009362 | denotes | metastases |
| T522 | 250-260 | D009362 | denotes | metastases |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 243-249 | HP_0002664 | denotes | cancer |
UseCases_ArguminSci_Discourse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T12 | 0-295 | DRI_Approach | denotes | Taken together, these findings suggest that A-NK cells may therefore use multiple MMPs in various cellular functions, including degradation of various extracellular matrix molecules as they extravasate from blood vessels and accumulate within cancer metastases following their adoptive transfer. |